|
|
Visual analysis of literature on the activating blood and resolving stasis in cardiovascular field |
XU Rongrong1,2 HU Yuanhui1,2 SHI Jingjing2 WANG Dandan1 |
1.The First Clinical Medical College, Shaanxi University of Chinese Medicine, Shaanxi Province, Xianyang 712000, China;
2.Department of Cardiology, Guang’anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China |
|
|
Abstract Objective To analyze the relevant literatures of activating blood and resolving stasis in the field of cardiovascular research in recent years, and study the development process, research hot spots and frontiers of this field. Methods A computer search was conducted on CNKI about the related literatures on the study of activating blood and resolving stasis in the cardiovascular field. CiteSpace software was used to analyze the visualization of the authors, institutions and keywords. Results In recent years, the main researchers in this field included Shi Dazhuo, Chen Keji, Wang Jie, etc. The core forces were Xiyuan Hospital of China Academy of Chinese Medical Sciences, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine and Beijing University of Chinese Medicine. Research hot spots were mainly on related diseases and their TCM syndromes, related prescriptions, mechanism, clinical efficacy and inspection indicators, and so on. In recent years, studies on Xuefu Zhuyu Tang and percutaneous coronary intervention have become hot spots. Conclusion This study reveals the development law of this field in the past ten years and provides reference for later related research.
|
|
|
|
|
[1] 刘永明,蒋梅先,陈铁军,等.从痰瘀论治冠心病的临床研究[J].辽宁中医杂志,2013,40(2):202-204.
[2] 刘要武.活血化瘀法治疗高血压45例远期疗效观察[J].光明中医,2014,29(6):1213-1214.
[3] 周安坤.老年心血管疾病的中医治疗探索[J].光明中医,2015,30(5):1064-1065.
[4] 胡盛寿,高润霖,刘力生,等.《中国心血管病报告2018》概要[J].中国循环杂志,2019,34(3):209-220.
[5] 吴小琳.急性心肌梗死再灌注治疗研究进展[J].现代诊断与治疗,2019,30(12):2007-2010.
[6] 于静,陈苏宁.从络论治胸痹病因、机、证、治探微[J].实用中医内科杂志,2020,34(5):81-84.
[7] 武云涛,田国祥,张薇.血管内皮功能失调与冠心病急性缺血发作的机制探讨[J].中国循证心血管医学杂志,2018, 10(7):888-890.
[8] 李玉莹,李佳玲,罗莉,等.双心疾病的中西医研究进展[J].湖南中医杂志,2020,36(6):148-149.
[9] 王玮琪,林平,刘国杰.膳食营养素与冠心病相关性研究进展[J].护理研究,2020,34(12):2155-2159.
[10] 魏栋梁,李凌基,高兵.叶天士通阳散结法辨治胸痹心痛探析[J].中医药临床杂志,2019,31(1):52-55.
[11] 左娇娇,王晓霞,张定华,等.炎症因子在糖尿病前期发病中的作用研究进展[J].中国医药导报,2020,17(3):38-40,44.
[12] Horr S,Nissen S. Managing hypertension in type 2 diabetes mellitus [J]. Best Pract Res Clin Endocrinol Metab,2016,30(3):445-454.
[13] 王晓丽,张慧玲,李雪靖,等.中药免煎颗粒替代中药饮片治疗高血压病效果的Meta分析[J].中国医药导报,2018,15(34):122-126.
[14] Choby B. Diabetes update:prevention and management of diabetes complications [J]. FP Essent,2017,456:36-40.
[15] 王梦梦,吉兰芳,崔树娜.丹参功效的物质基础研究进展[J].中医学报,2019,34(5):944-949.
[16] 王静,董振华,芦波,等.丹参活性成分及制剂在心血管病中的研究进展[J].时珍国医国药,2019,30(6):1453-1456.
[17] 李昕阳,刘素萍,王佳良,等.血府逐瘀汤联合针灸治疗缺血性脑卒中偏瘫患者的临床研究[J].中国医药导报,2020,17(5):137-140.
[18] 刘甜甜,姚魁武,段锦龙.血府逐瘀汤治疗心血管病的药理机制研究进展[J].吉林中医药,2019,39(10):1397-1400.
[19] 应萍,赵珍,许远.血府逐瘀汤联合西药治疗心绞痛临床观察[J].新中医,2018,50(8):40-42.
[20] 唐丹丽,石晓雯,周明眉,等.痰瘀同治方对缺氧复氧诱导心肌细胞AMPK-mTOR自噬信号通路的影响及机制[J].中国中西医结合杂志,2018,38(4):435-440.
[21] 俞平,马常娥,王婕.半夏白术天麻汤联合血府逐瘀汤对高血压患者内皮功能的影响[J].世界中医药,2019, 14(9):2408-2411.
[22] 郑智澜,兰雪.中西医结合治疗心血管临床试验的特点和方法[J].中西医结合心血管病电子杂志,2019,7(24):26.
[23] 肖蕾.中医体质与急性心梗发病及冠脉病变特点的相关性研究[D].沈阳:辽宁中医药大学,2019.
[24] 刘晓华.丹红注射液对冠心病介入治疗后血瘀证患者不良心血管事件的影响[J].世界复合医学,2019,5(5):148-150.
[25] 孟繁甦,曾建峰,吴汉辉,等.血府逐瘀汤对心血管疾病的临床作用及机制研究[J].亚太传统医药,2020,16(4):189-191. |
|
|
|